New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours... but experts fear NHS can't afford them
The UK is entering a ' cancer renaissance' with pioneering personalised vaccines to combat some of the deadliest tumours expected by 2030, say leading experts. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
How DOES the pioneering skin cancer vaccine work? When will patients be able to get hold of it? And could it really be a cure for deadly melanoma? All your questions answered...
Brits could be just over a year away from receiving a 'game-changer' jab on the NHS to treat one of the deadliest forms of skin cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
I took the world-first personalised cancer vaccine - it's my only hope of stopping deadly disease in its tracks
The music teacher, from Stevenage, is one of a handful of Brits to receive a world first personalised mRNA jab aimed at stopping this kind of skin cancer in its tracks. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
‘Real hope’ for cancer cure as personal mRNA vaccine for melanoma trialled
Excitement among patients and researchers as custom-built jabs enter phase 3 trialDoctors have begun trialling in hundreds of patients the world ’s first personalised mRNA cancer vaccine for melanoma, as experts hailed its “gamechanging” potential to permanently cure cancer.Melanoma affects about 132,000 people a year globally and is the biggest skin cancer killer. Currently, surgery is the main treatment although radiotherapy, medicines and chemotherapy are also sometimes used.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 26, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Cancer Skin cancer Drugs Medical research Science Health Vaccines and immunisation UK news UCL (University College London) Source Type: news
First personalised jab for skin cancer in UK trial
Steve Young is part of the tests to see if an mRNA jab can stop the deadliest skin cancer returning. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 26, 2024 Category: Consumer Health News Source Type: news
First mRNA skin-cancer vaccine starts UK trial
Steve Young is part of the tests to see if an mRNA jab can stop the deadliest skin cancer returning. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 26, 2024 Category: Consumer Health News Source Type: news
ESMO Recap: Adjuvant Vs. Neoadjuvant Therapy in Melanoma ESMO Recap: Adjuvant Vs. Neoadjuvant Therapy in Melanoma
Dr Jeffrey Weber discusses adjuvant and neoadjuvant therapy in melanoma.Medscape Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 25, 2024 Category: Radiology Tags: Hematology-Oncology Commentary Source Type: news
Woman given terminal diagnosis over mole living best life 30 years later
Growing up in the warm sunshine of the Australian eastern coast, life was good for a young mom enjoying a flourishing career in corporate Sydney, but she didn't know that she was about to encounter one of the hardest challenges anyone could be faced with. At the age of 32 and with a three-year-old…#australian #sydney #fionaaaron #melanoma #melbourne #sunshinecoast #queensland #nadia #ausaid #philippines (Source: Reuters: Health)
Source: Reuters: Health - April 21, 2024 Category: Consumer Health News Source Type: news
The Melanoma Research Foundation to host the New England Miles for Melanoma 5K
The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, care partners and thrivers. This year we will be hosting our annual New England event on Saturday, May... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 20, 2024 Category: Pharmaceuticals Source Type: news
Immunotherapy and Targeted Therapy Regimens for Melanoma Immunotherapy and Targeted Therapy Regimens for Melanoma
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
ESMO : Breakthroughs in Melanoma Treatment Regimens ESMO : Breakthroughs in Melanoma Treatment Regimens
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Students tackle gap in black and brown skin cancer diagnosis
Three medical students are solving the shocking disparity in skin cancer care between those with dark skin and those with white skin. (Source: University of Bristol news)
Source: University of Bristol news - April 11, 2024 Category: Universities & Medical Training Tags: Student life, Undergraduate, Health, Current students, Business and Enterprise; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news
Mayo Clinic Minute: Dermatologist explains light therapy for skin
Dermatologists advise their patients to avoid harmful ultraviolet light, which can cause skin damage, photoaging and skin cancer. But they also may prescribe light therapy to treat certain skin conditions. Light therapy is a treatment that uses different wavelengths of light to treat various skin conditions. In this Mayo Clinic Minute, Dr. Dawn Davis, a Mayo Clinic dermatologist, explains the different types of light therapy, what they treat, and if over-the-counter light therapy devices are… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 11, 2024 Category: Databases & Libraries Source Type: news
Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer
(MedPage Today) -- SAN DIEGO -- Patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) who received atezolizumab (Tecentriq) after undergoing multimodal definitive therapy failed to achieve a statistically meaningful... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 10, 2024 Category: Hematology Source Type: news
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
TUESDAY, April 9, 2024 -- The novel viral-based personalized cancer vaccine, TG4050, which encodes up to 30 patient- and tumor-specific sequences is feasible and safe for patients with resected head and neck squamous cell carcinoma, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
